guidelines. In reality the MAA acceptance takes 14 days on average and accelerated reviews are 6 months tops and often much less (4 months average for RTOR, for example).
GBM patients would prefer treatment from NWBO as soon as possible months not year as approvals is expected by the end of the year or first quarter of 2023 not in 2024. This refers to MHRA approval not the FDA. However, we have seen the FDA approve in less than 10 months.